患者エンゲージメントソリューション市場 : 2028年までの世界予測

Report Overview

The patient engagement solutions market is projected to reach USD 41.8 billion by 2028 from USD 22.5 billion in 2023, at a CAGR of 13.2% during the forecast period. Factors such as the growing demand for patient engagement solutions and the increasing utilization of m-health apps are driving the market growth.

However, high investment requirements for healthcare infrastructure and the scarcity of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period.

“Services segment is expected to grow at the highest rate from 2023 to 2028.”

By components, the patient engagement solutions market is divided into software, hardware, and services. The software segment holds the largest share of the global patient engagement solutions market in 2022. The hardware is further segmented into in-room televisions, integrated bedside terminals/assisted devices and tablets. The software market is further divided into standalone software and integrated software. In 2022, the integrated solutions segment holds the larger share of this market & is also projected to grow at the highest CAGR during the forecast period.
Nevertheless, the services segment is projected to exhibit the highest CAGR from 2023 to 2028. The notable growth in the services segment can be attributed to factors such as the increasing investments in the development of innovative service models that offer value-based, patient-centered care, driving the market growth for services.

“The on-premise solutions segment is anticipated to dominate the Patient Engagement Solutions market in 2023.”

When considering delivery modes, the patient engagement solutions market is categorized into on-premise and cloud-based/web-based modes. In 2023, it is projected that the on-premise solutions segment will command the largest share of the global patient engagement solutions market. However, the cloud-based/web-based mode segment is forecasted to exhibit the highest CAGR from 2023 to 2028. The substantial share of this segment can be attributed to the growth support provided by the flexibility, scalability, and affordability features inherent in cloud-based solutions within the patient engagement solutions market.

“In 2022, the Health management segment accounted for the largest share of the global patient engagement solutions market, by applications.”

By application, the patient engagement solutions market is divided into health management, home health management, social and behavioral management, and financial health management. In 2023, the health management applications segment accounts for the largest share of the global patient engagement solutions market.  Health management includes a wide range of patient engagement tools that help patients engage with their providers and take initiatives to improve or maintain their health status and increased awareness among patients about health conditions are the factors driving market growth.

“In 2022, Chronic diseases accounted for the largest share of the global patient engagement solutions market by therapeutic area.”

By therapeutic area, the patient engagement solutions market is divided into chronic diseases (cardiovascular disease, diabetes, obesity and other chronic diseases), women’s health, fitness, and other therapeutic areas. The chronic diseases segment dominated this market in 2022. In 2022, the cardiovascular diseases segment accounted for the largest share of the patient engagement solutions market for chronic diseases. However, the diabetes segment is projected to register the highest CAGR during the forecast period, owing to the high prevalence and incidence of diabetes worldwide.

“Patient/client scheduling accounted for the largest share of the global patient engagement solutions market, by functionality.”

By functionality, the patient engagement solutions market is divided into E-prescribing, document management, telehealth, patient/client scheduling, patient education, billing & payments and other functionalities. The patient/client scheduling segment accounted for the largest share of the patient engagement solutions market, by functionality, in 2022. The large share of the patient/client scheduling segment is mainly attributed to increasing government initiatives to boost patient engagement software adoption to provide quality care by physicians to their patients at lower costs.

“Providers’ segment accounted for the largest share of the global patient engagement solutions market by end user in 2022.”

By end users, the patient engagement solutions market is divided into providers, payers, patients, and other end users. The providers are further bifurcated into hospitals and healthcare systems, ambulatory care centers, home healthcare, and other providers. Moreover, the payers are further divided into private and public. By end users, the providers segment accounted for the largest share of the global patient engagement solutions market in 2022. The large share of this segment is due to the increasing implementation of patient engagement solutions to curtail mounting healthcare costs, offer value-based care, and expand financial outcomes are factors that are driving the growth of this segment.

“North America to dominate the patient engagement solutions market in 2022.”
In 2022, North America dominated the global patient engagement solutions market by region. Factors such as favorable government initiatives and regulations, the imperative to reduce healthcare costs, the increasing prevalence of chronic diseases, and the presence of key market players contribute significantly to the growth of the patient engagement solutions market in North America.

The Asia Pacific market is expected to achieve the highest CAGR during the forecast period from 2023 to 2028. This growth is attributed to the escalating adoption of Healthcare Information Technology (HCIT) solutions and the increasing prevalence of chronic diseases in the region. The rising patient volume and the growing need for accurate and timely diagnosis and treatment further contribute to the anticipated growth of the patient engagement solutions market in the Asia Pacific region.

Breakdown of supply-side primary interviews by company type, designation, and region:
• By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%)
• By Designation: C-level (44%), Director-level (35%), and Others (21%)
• By Region: North America (46%), Europe (26%), Asia Pacific (18%), Latin America (7%), and Middle East & Africa (10%)

McKesson Corporation (US), Veradigm (US), Oracle Corporation (US), Merative (US), Epic Systems Corporation (US), Orion Health (New Zealand), GetWellNetwork (US), athenahealth (US), Oneview Healthcare (Ireland), MEDITECH (US), IQVIA (US), Get Real Health (US), Cognizant (US), Harris Healthcare (US), Kareo (US), CureMD Healthcare (US), eClinicalWorks (US), and Lincor Solutions (US), AdvancedMD (US), Luma Health Inc. (US), WellStack(US), Vivify Health (US), Medhost (US), MEDISYSINC (US), and  Patient point LLC (US). These players are increasingly focusing on new product launches and partnerships to expand their product offerings in the patient engagement solutions market.

Research Coverage
• The report studies the Patient Engagement Solutions market based on component, delivery mode, therapeutic area, application, functionality, end user, and region. 
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total patient engagement solutions market.
• The report forecasts the revenue of market segments with respect to five majors regions.

Reasons to Buy the Report
• This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
• This report provides insights on:
• Analysis of key drivers (implementation of government regulations and initiatives to promote patient centric care, increasing adoption of patient engagement solutions, rising number of collaborations and partnerships between stakeholders, increasing utilization of mobile health apps), restraints (large investment requirement for healthcare infrastructure, protection of patient information, inadequate interoperability across healthcare providers and shortage of skilled IT professionals in the healthcare industry ), opportunities (growth opportunities in emerging markets, wearable health technology, cloud computing solutions), and challenges (high deployment cost of healthcare IT systems, low levels of healthcare literacy) impacting the growth of the Telehealth and Telemedicine market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the patient engagement solutions market.
• Market Development: Comprehensive information on the lucrative emerging markets, components, delivery mode, therapeutic area, application, functionality, end user, and region
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient engagement solutions market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Patient Engagement Market.

Table of Contents

1            INTRODUCTION            64

1.1         STUDY OBJECTIVES      64

1.2         MARKET DEFINITION   64

1.2.1      PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS    65

1.3         MARKET SCOPE             66

1.3.1      MARKETS COVERED     66

1.3.2      REGIONAL SEGMENTATION     67

1.3.3      YEARS CONSIDERED     67

1.4         CURRENCY CONSIDERED          68

1.5         STAKEHOLDERS            68

1.6         SUMMARY OF CHANGES            68

1.7         RECESSION IMPACT      69

2            RESEARCH METHODOLOGY     70

2.1         RESEARCH DATA           70

FIGURE 1           RESEARCH DESIGN       70

2.1.1      SECONDARY DATA       71

2.1.1.1   Key data from secondary sources     72

2.1.2      PRIMARY RESEARCH     73

2.1.3      PRIMARY SOURCES       73

2.1.4      KEY DATA FROM PRIMARY SOURCES    74

2.1.5      KEY INDUSTRY INSIGHTS          75

FIGURE 2           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    75

2.2         MARKET SIZE ESTIMATION METHODOLOGY    75

FIGURE 3           RESEARCH METHODOLOGY: HYPOTHESIS BUILDING  76

2.3         MARKET ESTIMATION  76

2.3.1      RESEARCH METHODOLOGY: MARKET ESTIMATION     77

2.3.2      APPROACH: END USER-BASED MARKET ESTIMATION   77

FIGURE 4           RESEARCH METHODOLOGY: MARKET ESTIMATION     78

2.3.3      TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION    78

2.3.4      TOP-DOWN APPROACH             78

2.3.5      BOTTOM-UP APPROACH           79

FIGURE 5           CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PATIENT ENGAGEMENT SOLUTIONS MARKET (2023–2028)           80

FIGURE 6           CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   81

2.4         MARKET DATA ESTIMATION AND TRIANGULATION     82

FIGURE 7           DATA TRIANGULATION METHODOLOGY         82

2.5         ASSUMPTIONS 83

2.6         LIMITATIONS   84

2.6.1      SCOPE-RELATED LIMITATIONS             84

2.6.2      METHODOLOGY-RELATED LIMITATIONS         84

2.7         RISK ASSESSMENT         84

TABLE 1             RISK ASSESSMENT: PATIENT ENGAGEMENT SOLUTIONS MARKET            84

2.8         PATIENT ENGAGEMENT SOLUTIONS MARKET: RECESSION IMPACT              84

3            EXECUTIVE SUMMARY 85

FIGURE 8           SOFTWARE TO BE LARGEST SEGMENT DURING FORECAST PERIOD              85

FIGURE 9           CLOUD-BASED/WEB-BASED MODE TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD     86

FIGURE 10         HEALTH MANAGEMENT TO DOMINATE PATIENT ENGAGEMENT SOLUTIONS MARKET DURING FORECAST PERIOD         87

FIGURE 11         PROVIDER TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD       87

FIGURE 12         GEOGRAPHICAL SNAPSHOT OF PATIENT ENGAGEMENT SOLUTIONS MARKET    88

4            PREMIUM INSIGHTS      89

4.1         ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET    89

FIGURE 13         GOVERNMENT INITIATIVES FOR PATIENT-CENTRIC CARE TO DRIVE MARKET 89

4.2         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE & COUNTRY (2022)     90

FIGURE 14         ON-PREMISE MODE ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022      90

4.3         PATIENT ENGAGEMENT SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES       91

FIGURE 15         ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       91

4.4         PATIENT ENGAGEMENT SOLUTIONS MARKET: REGIONAL MIX 91

FIGURE 16         ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD       91

4.5         PATIENT ENGAGEMENT SOLUTIONS MARKET: DEVELOPED VS. EMERGING ECONOMIES            92

FIGURE 17         EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD         92

5            MARKET OVERVIEW     93

5.1         INTRODUCTION            93

5.2         MARKET DYNAMICS     93

FIGURE 18         DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PATIENT ENGAGEMENT SOLUTIONS MARKET          93

5.2.1      DRIVERS            94

5.2.1.1   Implementation of government regulations and initiatives to promote patient-centric care          94

5.2.1.2   Increasing adoption of patient engagement solutions   95

5.2.1.3   Rising number of collaborations and partnerships between stakeholders  96

TABLE 2             INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2020 TO 2023   96

5.2.1.4   Increasing utilization of mobile health apps    97

5.2.1.5   Rising geriatric population and subsequent increase in prevalence of chronic diseases 97

FIGURE 19         GERIATRIC POPULATION, BY REGION, 2010–2030 (% OF TOTAL POPULATION) 98

5.2.2      RESTRAINTS     98

5.2.2.1   Large investment requirements for healthcare infrastructure     98

5.2.2.2   Protection of patient information     99

FIGURE 20         HEALTHCARE BREACHES REPORTED TO US DEPARTMENT OF HEALTH AND HUMAN SERVICES IN 2021            99

5.2.2.3   Inadequate interoperability across healthcare providers             99

5.2.2.4   Shortage of skilled IT professionals in healthcare industry          100

5.2.3      OPPORTUNITIES           100

5.2.3.1   Growth opportunities in emerging markets    100

5.2.3.2   Wearable health technology             101

5.2.3.3   Cloud-computing solutions 102

5.2.4      CHALLENGES   102

5.2.4.1   High deployment costs of healthcare IT systems          102

5.2.4.2   Low levels of healthcare literacy       103

5.3         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 103

FIGURE 21         REVENUE SHIFTS AND NEW REVENUE POCKETS FOR PATIENT ENGAGEMENT SOLUTIONS MARKET    103

5.4         INDUSTRY TRENDS       104

5.4.1      AI-DRIVEN DIGITAL TRANSFORMATION TO DRIVE NEXT WAVE OF PATIENT ENGAGEMENT            104

5.4.2      REAL-TIME REMOTE DIAGNOSIS TO BE INTEGRAL PART OF PATIENT ENGAGEMENT 104

5.4.3      ROLE OF MHEALTH IN PATIENT ENGAGEMENT             104

5.4.4      GROWING ADOPTION OF TELEMEDICINE         105

5.4.5      RISE OF SMART HOSPITAL ROOMS AND BEDSIDE TABLETS      105

5.4.6      GROWING DEMAND FOR VALUE-BASED HEALTHCARE 105

5.5         ECOSYSTEM ANALYSIS 106

FIGURE 22         PATIENT ENGAGEMENT SOLUTIONS MARKET: ECOSYSTEM ANALYSIS          106

5.6         VALUE CHAIN ANALYSIS            107

5.6.1      RESEARCH AND DEVELOPMENT            107

5.6.2      MATERIAL COMPONENTS         107

5.6.3      MANUFACTURERS AND DEVELOPERS  107

5.6.4      DISTRIBUTION AND SALES       107

5.6.5      END-USER INDUSTRIES 107

5.6.6      POST-SALE SERVICES   107

FIGURE 23         PATIENT ENGAGEMENT SOLUTIONS MARKET: VALUE CHAIN ANALYSIS          108

5.7         TECHNOLOGY ANALYSIS           108

5.7.1      ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML)              108

5.7.2      VIRTUAL REALITY (VR) AND AUGMENTED REALITY (AR)          108

5.7.3      REMOTE MONITORING DEVICES AND WEARABLES       108

5.8         TARIFF AND REGULATORY ANALYSIS   109

5.8.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          109

TABLE 3             NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         109

TABLE 4             EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111

TABLE 5             ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         112

TABLE 6             REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         113

5.8.2      NORTH AMERICA          114

5.8.2.1   US         114

5.8.2.1.1 Health Insurance Portability and Accountability Act of 1996 (HIPAA)    114

5.8.2.1.2 Health Information Technology for Economic and Clinical Health Act of 2009 (HITECh)           114

5.8.2.1.3 Consumer Privacy Protection Act of 2017      114

5.8.2.1.4 Affordable Care Act, 2010 114

5.8.2.2   Canada  114

5.8.2.2.1 Personal Information Protection and Electronic Documents Act (PIPEDA)              114

5.8.3      EUROPE             115

5.8.3.1   General Data Protection Regulation (GDPR), European Union (EU)     115

5.8.3.2   EU Cybersecurity Act        115

5.8.3.3   Germany             115

5.8.3.3.1 German Data Protection Act (Bundesdatenschutzgesetz, BDSG)            115

5.8.3.4   France   115

5.8.3.4.1 French Data Protection Act             115

5.8.3.5   Italy       116

5.8.3.5.1 Personal Data Protection Code (Legislative Decree 196/2003) 116

5.8.4      ASIA PACIFIC    116

5.8.4.1   China     116

5.8.4.1.1 Cybersecurity Law of People’s Republic of China         116

5.8.4.2   Japan     116

5.8.4.2.1 Act on Protection of Personal Information (APPI)      116

5.8.4.3   India      116

5.8.4.3.1 The Information Technology Act, 2000         116

5.8.5      LATIN AMERICA             116

5.8.5.1   Protection of Personal Information Act          116

5.8.6      MIDDLE EAST & AFRICA             117

5.8.6.1   Private Cloud Computing Regulatory Framework        117

5.9         PRICING ANALYSIS        117

5.9.1      PRICING OVERVIEW     117

FIGURE 24         PATIENT ENGAGEMENT SOLUTIONS MARKET: PRICING COMPONENTS 117

5.9.2      AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION              118

FIGURE 25         AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION  118

TABLE 7             AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION  119

5.9.3      INDICATIVE PRICING ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS      119

TABLE 8             INDICATIVE PRICING ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS      119

5.10       TRADE ANALYSIS          120

FIGURE 26         EXPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022 (USD THOUSAND) 120

FIGURE 27         IMPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022 (USD THOUSAND) 121

5.11       PORTER’S FIVE FORCES ANALYSIS         121

TABLE 9             PATIENT ENGAGEMENT SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS         121

5.11.1    INTENSITY OF COMPETITIVE RIVALRY 122

5.11.2    BARGAINING POWER OF SUPPLIERS     122

5.11.3    BARGAINING POWER OF BUYERS           122

5.11.4    THREAT OF NEW ENTRANTS    122

5.11.5    THREAT OF SUBSTITUTES         122

5.12       PATENT ANALYSIS        123

5.12.1    PATENT PUBLICATION TRENDS FOR PATIENT ENGAGEMENT SOLUTIONS      123

FIGURE 28         PATENT PUBLICATION TRENDS (JANUARY 2012–NOVEMBER 2023)    123

5.12.2    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS        123

FIGURE 29         TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATIENT ENGAGEMENT SOLUTIONS (JANUARY 2012–NOVEMBER 2023)              124

FIGURE 30         TOP APPLICANT COUNTRIES/REGIONS FOR PATIENT ENGAGEMENT SOLUTIONS PATENTS DOCUMENTS      124

TABLE 10           PATIENT ENGAGEMENT SOLUTIONS MARKET: LIST OF MAJOR PATENTS           125

5.13       KEY STAKEHOLDERS AND BUYING CRITERIA    127

5.13.1    KEY STAKEHOLDERS IN BUYING PROCESS         127

TABLE 11           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PATIENT ENGAGEMENT SOLUTIONS   127

FIGURE 31         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PATIENT ENGAGEMENT SOLUTIONS   128

TABLE 12           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) FOR PATIENT ENGAGEMENT SOLUTIONS   128

5.13.2    BUYING CRITERIA         129

FIGURE 32         KEY BUYING CRITERIA FOR PATIENT ENGAGEMENT SOLUTIONS      129

TABLE 13           KEY BUYING CRITERIA FOR PATIENT ENGAGEMENT SOLUTION COMPONENTS         129

5.14       END USER ANALYSIS     130

5.14.1    UNMET NEEDS 130

TABLE 14           UNMET NEEDS IN PATIENT ENGAGEMENT SOLUTIONS MARKET            130

5.14.2    END USER EXPECTATIONS        131

TABLE 15           END USER EXPECTATIONS IN PATIENT ENGAGEMENT SOLUTIONS MARKET    131

5.15       KEY CONFERENCES & EVENTS IN 2023–2024       132

TABLE 16           PATIENT ENGAGEMENT SOLUTIONS: DETAILED LIST OF CONFERENCES & EVENTS          132

5.16       REPLACEMENT TRENDS FOR PATIENT ENGAGEMENT SOLUTIONS              133

5.17       PATIENT ENGAGEMENT SOLUTIONS INVESTMENT LANDSCAPE              134

FIGURE 33         INVESTOR DEALS AND FUNDING IN PATIENT ENGAGEMENT SOLUTIONS SOARED IN 2022     134

FIGURE 34         MOST VALUED PATIENT ENGAGEMENT SOLUTION FIRMS IN 2022 (USD BILLION)      134

5.18       PATIENT ENGAGEMENT SOLUTIONS BUSINESS MODELS           135

5.18.1    SUBSCRIPTION-BASED MODEL 135

5.18.2    LICENSING MODEL       135

5.18.3    HYBRID MODEL             135

5.18.4    FREEMIUM MODEL       135

5.18.5    VALUE-BASED PRICING MODEL             135

5.18.6    DATA MONETIZATION 135

5.18.7    CUSTOM DEVELOPMENT/CONSULTING MODEL           135

5.18.8    INTEGRATION WITH EXISTING SYSTEMS           135

5.18.9    PARTNERSHIPS WITH HEALTHCARE PROVIDERS           136

5.18.10  WHITE-LABEL SOLUTIONS        136

5.18.11  OPEN-SOURCE SOFTWARE        136

5.19       USE CASES/CASE STUDIES         136

5.19.1    FOCUS ON REDUCING READMISSION RATES AND IMPROVING CARE              136

5.19.1.1 Use case 1: Need to reduce patient hospital stays         136

5.19.2    IMPROVE OUTPATIENT COMMUNICATION      136

5.19.2.1 Case 2: Rising need to curb miscommunication with discharged patients 136

5.19.3    PATIENT ENGAGEMENT STRATEGY      137

5.19.3.1 Use case 3: Post-discharge care        137

5.19.4    AN EMR-AGNOSTIC PATIENT ENGAGEMENT PLATFORM WITH COMPREHENSIVE BUILT-IN CAPABILITIES        137

5.19.4.1 Use case 4: To improve patient engagement, giving patients ability to access all their medical information in one place           137

6            PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT              138

6.1         INTRODUCTION            139

TABLE 17           PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)           139

6.2         HARDWARE      139

6.2.1      INTERACTIVE EXPERIENCE FOR PATIENTS & FAMILIES 139

TABLE 18           HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)              140

TABLE 19           HARDWARE MARKET, BY REGION, 2021–2028 (USD MILLION)              140

TABLE 20           NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)      140

TABLE 21           EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)   141

TABLE 22           ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)        141

TABLE 23           LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)      142

TABLE 24           MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)      142

6.2.2      IN-ROOM TELEVISIONS             142

6.2.2.1   Increase in adoption of in-room televisions by hospitals             142

TABLE 25           IN-ROOM TELEVISIONS MARKET, BY REGION, 2021–2028 (USD MILLION)          143

TABLE 26           NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021–2028 (USD MILLION)              143

TABLE 27           EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021–2028 (USD MILLION)          143

TABLE 28           ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021–2028 (USD MILLION)  144

TABLE 29           LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021–2028 (USD MILLION)              144

TABLE 30           MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021–2028 (USD MILLION)              144

6.2.3      INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES            145

6.2.3.1   Integrated bedside terminals enhance patient experience           145

TABLE 31           INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)            145

TABLE 32           NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)    145

TABLE 33           EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)     146

TABLE 34           ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)          146

TABLE 35           LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)    147

TABLE 36           MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)    147

6.2.4      TABLETS           147

6.2.4.1   Portability and cost-effectiveness of tablets support growth       147

TABLE 37           TABLETS MARKET, BY REGION, 2021–2028 (USD MILLION)              148

TABLE 38           NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021–2028 (USD MILLION)           148

TABLE 39           EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021–2028 (USD MILLION)        149

TABLE 40           ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021–2028 (USD MILLION)             149

TABLE 41           LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021–2028 (USD MILLION)           150

TABLE 42           MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021–2028 (USD MILLION)           150

6.3         SOFTWARE       150

TABLE 43           SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)              151

TABLE 44           SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)              151

TABLE 45           NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)       151

TABLE 46           EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)    152

TABLE 47           ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)          152

TABLE 48           LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)       153

TABLE 49           MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)       153

6.3.1      STANDALONE SOFTWARE         153

6.3.1.1   Standalone software refers to traditional software installed in client systems              153

TABLE 50           STANDALONE SOLUTIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 154

TABLE 51           NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)          154

TABLE 52           EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)    155

TABLE 53           ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)              155

TABLE 54           LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)          156

TABLE 55           MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)          156

6.3.2      INTEGRATED SOFTWARE          156

6.3.2.1   Reduction in time spent on data management to drive growth   156

TABLE 56           INTEGRATED SOLUTIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 157

TABLE 57           NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)          157

TABLE 58           EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)     158

TABLE 59           ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)              158

TABLE 60           LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)          159

TABLE 61           MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)          159

6.4         SERVICES          159

TABLE 62           SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)              160

TABLE 63           NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)          160

TABLE 64           EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)       161

TABLE 65           ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)             161

TABLE 66           LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)          162

TABLE 67           MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)          162

7            PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE              163

7.1         INTRODUCTION            164

TABLE 68           PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)          164

7.2         ON-PREMISE MODE      164

7.2.1      PATIENT DATA SAFETY AND COST BENEFITS TO DRIVE MARKET              164

TABLE 69           ON-PREMISE MODE MARKET, BY REGION, 2021–2028 (USD MILLION)          165

TABLE 70           NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021–2028 (USD MILLION)              165

TABLE 71           EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021–2028 (USD MILLION)   166

TABLE 72           ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021–2028 (USD MILLION)        166

TABLE 73           LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021–2028 (USD MILLION)              167

TABLE 74           MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021–2028 (USD MILLION)              167

7.3         CLOUD-BASED/ WEB-BASED MODE      167

7.3.1      REGULATORY REQUIREMENTS DRIVE HEALTHCARE PROVIDERS TO ADOPT CLOUD-BASED SOLUTIONS      167

TABLE 75           CLOUD-BASED/WEB-BASED MODE MARKET, BY REGION, 2021–2028 (USD MILLION)          168

TABLE 76           NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021–2028 (USD MILLION)              169

TABLE 77           EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021–2028 (USD MILLION)             169

TABLE 78           ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021–2028 (USD MILLION)    169

TABLE 79           LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021–2028 (USD MILLION)              170

TABLE 80           MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021–2028 (USD MILLION)              170

8            PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION              171

8.1         INTRODUCTION            172

TABLE 81           PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           172

8.2         HEALTH MANAGEMENT            172

8.2.1      HEALTH MANAGEMENT PLAYS CRUCIAL TOOL IN GUIDING PATIENTS IN SELF-CARE   172

TABLE 82           PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY REGION, 2021–2028 (USD MILLION) 173

TABLE 83           NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)          173

TABLE 84           EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)         174

TABLE 85           ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION) 174

TABLE 86           LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)          175

TABLE 87           MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)          175

8.3         HOME HEALTH MANAGEMENT 175

8.3.1      GROWING PREFERENCE FOR HOME HEALTHCARE TO SUPPORT MARKET GROWTH        175

TABLE 88           PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY REGION, 2021–2028 (USD MILLION)             176

TABLE 89           NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)          176

TABLE 90           EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)              177

TABLE 91           ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)              177

TABLE 92           LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)          178

TABLE 93           MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)          178

8.4         SOCIAL & BEHAVIORAL MANAGEMENT 178

8.4.1      GROWING POPULARITY OF SOCIAL MEDIA TO DRIVE MARKET GROWTH          178

TABLE 94           PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY REGION, 2021–2028 (USD MILLION)    179

TABLE 95           NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION) 179

TABLE 96           EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)          180

TABLE 97           ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)          180

TABLE 98           LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION) 181

TABLE 99           MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION) 181

8.5         FINANCIAL HEALTH MANAGEMENT     181

8.5.1      FINANCIAL ENGAGEMENT SOLUTIONS HELP PROVIDERS MANAGE PATIENT PAYMENTS    181

TABLE 100         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY REGION, 2021–2028 (USD MILLION)             182

TABLE 101         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION) 182

TABLE 102         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)              183

TABLE 103         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)          183

TABLE 104         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION) 184

TABLE 105         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION) 184

9            PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA    185

9.1         INTRODUCTION            186

TABLE 106         PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)             186

9.2         CHRONIC DISEASES      186

TABLE 107         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY REGION, 2021–2028 (USD MILLION)           187

TABLE 108         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2021–2028 (USD MILLION)  187

TABLE 109         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)              187

TABLE 110         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)   188

TABLE 111         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)        188

TABLE 112         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)              189

TABLE 113         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)              189

9.2.1      CARDIOVASCULAR DISEASES (CVD)      189

9.2.1.1   Leading cause of death worldwide   189

TABLE 114         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION)    190

TABLE 115         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)          190

TABLE 116         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 191

TABLE 117         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)              191

TABLE 118         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)          192

TABLE 119         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)          192

9.2.2      DIABETES         192

9.2.2.1   High incidence of diabetes worldwide drives growth    192

TABLE 120         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY REGION, 2021–2028 (USD MILLION)  193

TABLE 121         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION)         193

TABLE 122         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION)      194

TABLE 123         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION)            194

TABLE 124         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION)         195

TABLE 125         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION)         195

9.2.3      OBESITY            195

9.2.3.1   Rising prevalence of obesity to drive growth   195

TABLE 126         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY REGION, 2021–2028 (USD MILLION)  196

TABLE 127         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021–2028 (USD MILLION)            196

TABLE 128         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021–2028 (USD MILLION)        197

TABLE 129         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021–2028 (USD MILLION) 197

TABLE 130         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021–2028 (USD MILLION)            198

TABLE 131         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021–2028 (USD MILLION)            198

9.2.4      OTHER CHRONIC DISEASES      198

TABLE 132         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2021–2028 (USD MILLION)       199

TABLE 133         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)          199

TABLE 134         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)   200

TABLE 135         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)              200

TABLE 136         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)          201

TABLE 137         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)          201

9.3         WOMEN’S HEALTH       201

9.3.1      INCREASING SELF-AWARENESS FOR MANAGEMENT OF DISEASES TO DRIVE MARKET 201

TABLE 138         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY REGION, 2021–2028 (USD MILLION)             202

TABLE 139         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY COUNTRY, 2021–2028 (USD MILLION)              202

TABLE 140         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY COUNTRY, 2021–2028 (USD MILLION)    203

TABLE 141         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY COUNTRY, 2021–2028 (USD MILLION)          203

TABLE 142         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY COUNTRY, 2021–2028 (USD MILLION)              204

TABLE 143         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY COUNTRY, 2021–2028 (USD MILLION)              204

9.4         FITNESS             204

9.4.1      GROWING PREFERENCE FOR HEALTHY LIFESTYLE TO SUPPORT MARKET GROWTH        204

TABLE 144         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY REGION, 2021–2028 (USD MILLION)  205

TABLE 145         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021–2028 (USD MILLION)            205

TABLE 146         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021–2028 (USD MILLION)         206

TABLE 147         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021–2028 (USD MILLION) 206

TABLE 148         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021–2028 (USD MILLION)            207

TABLE 149         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021–2028 (USD MILLION)            207

9.5         OTHER THERAPEUTIC AREAS   207

TABLE 150         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2021–2028 (USD MILLION)   208

TABLE 151         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021–2028 (USD MILLION)          208

TABLE 152         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021–2028 (USD MILLION)              209

TABLE 153         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021–2028 (USD MILLION)              209

TABLE 154         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021–2028 (USD MILLION)          210

TABLE 155         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021–2028 (USD MILLION)          210

10          PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY              211

10.1       INTRODUCTION            212

TABLE 156         PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     212

10.2       PATIENT/CLIENT SCHEDULING            212

10.2.1    STREAMLINING OF WORKFLOWS AND EFFICIENT MANAGEMENT OF PATIENT SCHEDULES  212

TABLE 157         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY REGION, 2021–2028 (USD MILLION)              213

TABLE 158         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021–2028 (USD MILLION)          213

TABLE 159         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021–2028 (USD MILLION)              214

TABLE 160         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021–2028 (USD MILLION)              214

TABLE 161         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021–2028 (USD MILLION)          215

TABLE 162         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021–2028 (USD MILLION)          215

10.3       TELEHEALTH   215

10.3.1    FLEXIBILITY IN TREATMENT OPTIONS DUE TO REMOTE MONITORING   215

TABLE 163         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY REGION, 2021–2028 (USD MILLION)   216

TABLE 164         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021–2028 (USD MILLION)   216

TABLE 165         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021–2028 (USD MILLION) 217

TABLE 166         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021–2028 (USD MILLION)     217

TABLE 167         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021–2028 (USD MILLION)   218

TABLE 168         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021–2028 (USD MILLION)   218

10.4       E-PRESCRIBING             218

10.4.1    COST-EFFECTIVE METHOD TO ENHANCE DECISION-MAKING 218

TABLE 169         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY REGION, 2021–2028 (USD MILLION)    219

TABLE 170         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021–2028 (USD MILLION)              219

TABLE 171         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021–2028 (USD MILLION)          220

TABLE 172         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021–2028 (USD MILLION)  220

TABLE 173         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021–2028 (USD MILLION)              221

TABLE 174         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021–2028 (USD MILLION)              221

10.5       DOCUMENT MANAGEMENT     221

10.5.1    EFFECTIVE MANAGEMENT OF PATIENT DOCUMENTS CRUCIAL FOR HEALTHCARE PROVIDERS         221

TABLE 175         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2021–2028 (USD MILLION)      222

TABLE 176         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)          222

TABLE 177         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)  223

TABLE 178         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)              223

TABLE 179         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)          224

TABLE 180         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)          224

10.6       BILLING & PAYMENTS  224

10.6.1    DEMAND FOR STREAMLINED PROCESSES TO DRIVE MARKET GROWTH          224

TABLE 181         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY REGION, 2021–2028 (USD MILLION)        225

TABLE 182         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021–2028 (USD MILLION)              225

TABLE 183         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021–2028 (USD MILLION)             226

TABLE 184         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021–2028 (USD MILLION)    226

TABLE 185         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021–2028 (USD MILLION)              227

TABLE 186         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021–2028 (USD MILLION)              227

10.7       PATIENT EDUCATION  227

10.7.1    RISING DEMAND FOR INFORMED HEALTHCARE TO DRIVE MARKET GROWTH          227

TABLE 187         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY REGION, 2021–2028 (USD MILLION)     228

TABLE 188         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021–2028 (USD MILLION)              228

TABLE 189         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021–2028 (USD MILLION)            229

TABLE 190         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021–2028 (USD MILLION)    229

TABLE 191         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021–2028 (USD MILLION)              230

TABLE 192         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021–2028 (USD MILLION)              230

10.8       OTHER FUNCTIONALITIES        230

TABLE 193         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY REGION, 2021–2028 (USD MILLION)        231

TABLE 194         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)          231

TABLE 195         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)    232

TABLE 196         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)              232

TABLE 197         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)          233

TABLE 198         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)          233

11          PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER    234

11.1       INTRODUCTION            235

TABLE 199         PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)          235

11.2       PROVIDERS       235

11.2.1    LARGEST END USERS OF PATIENT ENGAGEMENT SOLUTIONS 235

TABLE 200         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2021–2028 (USD MILLION)            236

TABLE 201         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY REGION, 2021–2028 (USD MILLION)       236

TABLE 202         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)      237

TABLE 203         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)   237

TABLE 204         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)         237

TABLE 205         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)      238

TABLE 206         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)      238

11.2.2    HOSPITALS & HEALTHCARE SYSTEMS  238

11.2.2.1 Hospitals and healthcare systems contribute highest share         238

TABLE 207         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY REGION, 2021–2028 (USD MILLION)              239

TABLE 208         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 239

TABLE 209         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)          240

TABLE 210         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)          240

TABLE 211         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 241

TABLE 212         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 241

11.2.3    AMBULATORY CARE CENTERS 241

11.2.3.1 Gradual shift of patient care from inpatient to outpatient settings to drive growth              241

TABLE 213         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2021–2028 (USD MILLION)  242

TABLE 214         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)          242

TABLE 215         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)              243

TABLE 216         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)              243

TABLE 217         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)          244

TABLE 218         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)          244

11.2.4    HOME CARE CENTERS  244

11.2.4.1 Rise in global geriatric population requiring long-term care to support market growth   244

TABLE 219         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY REGION, 2021–2028 (USD MILLION) 245

TABLE 220         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)              245

TABLE 221         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)            246

TABLE 222         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)    246

TABLE 223         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)              247

TABLE 224         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)              247

11.2.5    OTHER PROVIDERS       247

TABLE 225         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY REGION, 2021–2028 (USD MILLION)       248

TABLE 226         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)              248

TABLE 227         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)   249

TABLE 228         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)         249

TABLE 229         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)              250

TABLE 230         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)              250

11.3       PAYERS 250

11.3.1    PATIENT ENGAGEMENT SOLUTIONS HELP HEALTHCARE PAYERS MINIMIZE ERRORS         250

TABLE 231         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2021–2028 (USD MILLION)       251

TABLE 232         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY REGION, 2021–2028 (USD MILLION)  251

TABLE 233         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 252

TABLE 234         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)          252

TABLE 235         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)  252

TABLE 236         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 253

TABLE 237         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 253

11.3.2    PRIVATE            253

11.3.2.1 Private payers partnering with telehealth vendors for seamless healthcare solutions              253

TABLE 238         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY REGION, 2021–2028 (USD MILLION) 254

TABLE 239         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)              254

TABLE 240         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)        255

TABLE 241         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)             255

TABLE 242         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)              256

TABLE 243         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)              256

11.3.3    PUBLIC 256

11.3.3.1 Investments made by public payers to support market  256

TABLE 244         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY REGION, 2021–2028 (USD MILLION) 257

TABLE 245         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)              257

TABLE 246         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)          258

TABLE 247         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)  258

TABLE 248         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)              259

TABLE 249         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)              259

11.4       PATIENTS         259

11.4.1    PATIENT ENGAGEMENT SOLUTIONS MOTIVATE INDIVIDUALS TO MONITOR AND IMPROVE HEALTH OUTCOMES 259

TABLE 250         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY REGION, 2021–2028 (USD MILLION)  260

TABLE 251         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)         260

TABLE 252         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)      261

TABLE 253         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)            261

TABLE 254         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)         262

TABLE 255         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)         262

11.5       OTHER END USERS        262

TABLE 256         PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)        263

TABLE 257         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)              263

TABLE 258         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)    264

TABLE 259         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)         264

TABLE 260         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)              265

TABLE 261         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)              265

12          PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION       266

12.1       INTRODUCTION            267

TABLE 262         PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2021–2028 (USD MILLION)          267

12.2       NORTH AMERICA          267

FIGURE 35         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT     268

12.2.1    RECESSION IMPACT      268

TABLE 263         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         269

TABLE 264         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)  269

TABLE 265         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)         270

TABLE 266         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)          270

TABLE 267         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)          270

TABLE 268         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  271

TABLE 269         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)    271

TABLE 270         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)           272

TABLE 271         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)          272

TABLE 272         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)         273

TABLE 273         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          273

TABLE 274         NORTH AMERICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)   274

12.2.2    US         274

12.2.2.1 High healthcare expenditure and affordable costs to drive market            274

TABLE 275         US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)           275

TABLE 276        US: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)       275

TABLE 277         US: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)       276

TABLE 278         US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)     276

TABLE 279         US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           276

TABLE 280         US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)             277

TABLE 281         US: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)    277

TABLE 282         US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     278

TABLE 283         US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)             278

TABLE 284         US: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)       279

TABLE 285         US: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)             279

12.2.3    CANADA            279

12.2.3.1 Growing need for cost containment to drive market     279

TABLE 286         CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)           280

TABLE 287         CANADA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    281

TABLE 288         CANADA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    281

TABLE 289         CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)     281

TABLE 290         CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           282

TABLE 291         CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)             282

TABLE 292         CANADA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)  283

TABLE 293         CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     283

TABLE 294         CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)    284

TABLE 295         CANADA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    284

TABLE 296         CANADA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    284

12.3       EUROPE             285

12.3.1    RECESSION IMPACT      285

TABLE 297         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    285

TABLE 298         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)           286

TABLE 299         EUROPE: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    286

TABLE 300         EUROPE: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    286

TABLE 301         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)     287

TABLE 302         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           287

TABLE 303         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)             287

TABLE 304         EUROPE: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)  288

TABLE 305         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     288

TABLE 306         EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)    289

TABLE 307         EUROPE: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    289

TABLE 308         EUROPE: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    289

12.3.2    GERMANY         290

12.3.2.1 Growing demand for effective patient records management to drive market              290

TABLE 309         GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)           290

TABLE 310         GERMANY: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    291

TABLE 311         GERMANY: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    291

TABLE 312         GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)     291

TABLE 313         GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           292

TABLE 314         GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)             292

TABLE 315         GERMANY: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)  293

TABLE 316         GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     293

TABLE 317         GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)    294

TABLE 318         GERMANY: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    294

TABLE 319         GERMANY: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    294

12.3.3    FRANCE             295

12.3.3.1 Digital health insurance startups to drive market         295

TABLE 320         FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)           295

TABLE 321         FRANCE: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    296

TABLE 322         FRANCE: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    296

TABLE 323         FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)     296

TABLE 324         FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           297

TABLE 325         FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)             297

TABLE 326         FRANCE: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)  298

TABLE 327         FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     298

TABLE 328         FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)    299

TABLE 329         FRANCE: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    299

TABLE 330        FRANCE: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)       299

12.3.4    UK         300

12.3.4.1 Favorable government initiatives promoting healthcare to drive market   300

TABLE 331         UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)           300

TABLE 332         UK: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    301

TABLE 333         UK: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)       301

TABLE 334         UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)     301

TABLE 335         UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           302

TABLE 336         UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)             302

TABLE 337         UK: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)    303

TABLE 338         UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     303

TABLE 339         UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)             304

TABLE 340         UK: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)       304

TABLE 341         UK: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)             304

12.3.5    SPAIN   305

12.3.5.1 Enhanced ability for monitoring patients and chronic illnesses to drive market              305

TABLE 342         SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)           305

TABLE 343         SPAIN: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    306

TABLE 344         SPAIN: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    306

TABLE 345         SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)     306

TABLE 346         SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           307

TABLE 347         SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)             307

TABLE 348         SPAIN: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)  308

TABLE 349         SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     308

TABLE 350         SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)             309

TABLE 351         SPAIN: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    309

TABLE 352         SPAIN: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)       309

12.3.6    ITALY   310

12.3.6.1 Growing burden of chronic diseases and shortage of healthcare workers to drive market   310

TABLE 353         ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)           310

TABLE 354         ITALY: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    310

TABLE 355         ITALY: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    311

TABLE 356         ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)     311

TABLE 357         ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           311

TABLE 358         ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)             312

TABLE 359         ITALY: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)  312

TABLE 360         ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     313

TABLE 361         ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)             313

TABLE 362         ITALY: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    314

TABLE 363         ITALY: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)       314

12.3.7    REST OF EUROPE           314

TABLE 364         REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)  315

TABLE 365         REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)         315

TABLE 366         REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)          316

TABLE 367         REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)          316

TABLE 368         REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  316

TABLE 369         REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)    317

TABLE 370         REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)           317

TABLE 371         REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)          318

TABLE 372         REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)         318

TABLE 373         REST OF EUROPE: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          319

TABLE 374         REST OF EUROPE: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    319

12.4       ASIA PACIFIC    319

12.4.1    RECESSION IMPACT      320

FIGURE 36         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT        321

TABLE 375         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            322

TABLE 376         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)      322

TABLE 377         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)         322

TABLE 378         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)          323

TABLE 379         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 323

TABLE 380         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)     323

TABLE 381         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)        324

TABLE 382         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)  324

TABLE 383         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 325

TABLE 384         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)            325

TABLE 385         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    326

TABLE 386         ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    326

12.4.2    JAPAN  326

12.4.2.1 Rising geriatric population to drive market     326

TABLE 387         JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)           327

TABLE 388         JAPAN: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    327

TABLE 389         JAPAN: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    328

TABLE 390         JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)     328

TABLE 391         JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           328

TABLE 392         JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)             329

TABLE 393         JAPAN: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)  329

TABLE 394         JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     330

TABLE 395         JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)             330

TABLE 396         JAPAN: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    331

TABLE 397         JAPAN: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)       331

12.4.3    CHINA  331

12.4.3.1 Implementation of EMR solutions by government to drive market           331

TABLE 398         CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)           332

TABLE 399         CHINA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    332

TABLE 400         CHINA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    333

TABLE 401         CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)     333

TABLE 402         CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           333

TABLE 403         CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)             334

TABLE 404         CHINA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)  334

TABLE 405         CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     335

TABLE 406         CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)             335

TABLE 407         CHINA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    336

TABLE 408         CHINA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)       336

12.4.4    INDIA   336

12.4.4.1 High burden of chronic diseases to drive market          336

TABLE 409         INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)           337

TABLE 410         INDIA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    337

TABLE 411         INDIA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    338

TABLE 412         INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)     338

TABLE 413         INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           338

TABLE 414         INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)             339

TABLE 415         INDIA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)  339

TABLE 416         INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     340

TABLE 417         INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)             340

TABLE 418         INDIA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    341

TABLE 419         INDIA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)       341

12.4.5    REST OF ASIA PACIFIC  341

TABLE 420         REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)  342

TABLE 421         REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)         343

TABLE 422         REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)          343

TABLE 423         REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)          343

TABLE 424         REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  344

TABLE 425         REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)    344

TABLE 426         REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)           345

TABLE 427         REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)          345

TABLE 428         REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)         346

TABLE 429         REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          346

TABLE 430         REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)   346

12.5       LATIN AMERICA             347

12.5.1    RECESSION IMPACT      347

TABLE 431         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         348

TABLE 432         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)  348

TABLE 433         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)         348

TABLE 434         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)          349

TABLE 435         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)          349

TABLE 436         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  349

TABLE 437         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)    350

TABLE 438         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)           350

TABLE 439         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)          351

TABLE 440         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)         351

TABLE 441         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          352

TABLE 442         LATIN AMERICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    352

12.5.2    BRAZIL 352

12.5.2.1 Growing emphasis on reducing healthcare costs to drive market 352

TABLE 443         BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)           353

TABLE 444         BRAZIL: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    353

TABLE 445         BRAZIL: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    353

TABLE 446         BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)     354

TABLE 447         BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           354

TABLE 448         BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)             354

TABLE 449         BRAZIL: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)  355

TABLE 450         BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     355

TABLE 451         BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)    356

TABLE 452         BRAZIL: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    356

TABLE 453         BRAZIL: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)       356

12.5.3    MEXICO             357

12.5.3.1 Increasing demand and adoption of healthcare IT solutions to drive market              357

TABLE 454         MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)           357

TABLE 455         MEXICO: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    358

TABLE 456         MEXICO: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)    358

TABLE 457         MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)     358

TABLE 458         MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           359

TABLE 459         MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)             359

TABLE 460         MEXICO: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)  360

TABLE 461         MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     360

TABLE 462         MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)    361

TABLE 463         MEXICO: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    361

TABLE 464        MEXICO: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)       361

12.5.4    REST OF LATIN AMERICA          362

TABLE 465         REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)        362

TABLE 466         REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION) 363

TABLE 467         REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)  363

TABLE 468         REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)  363

TABLE 469         REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)       364

TABLE 470         REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)              364

TABLE 471         REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)              365

TABLE 472         REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)  365

TABLE 473         REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 366

TABLE 474         REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          366

TABLE 475         REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)   366

12.6       MIDDLE EAST & AFRICA             367

12.6.1    RECESSION IMPACT      367

TABLE 476         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         367

TABLE 477         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)  368

TABLE 478         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)         368

TABLE 479         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)          368

TABLE 480         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)          369

TABLE 481         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  369

TABLE 482         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)    369

TABLE 483         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)           370

TABLE 484         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)          370

TABLE 485         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)         371

TABLE 486         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          371

TABLE 487         MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)   371

12.6.2    GCC COUNTRIES           372

12.6.2.1 Initiatives for improving present health infrastructure to drive market     372

TABLE 488         GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)  373

TABLE 489         GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)         373

TABLE 490         GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)          373

TABLE 491         GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)          374

TABLE 492         GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  374

TABLE 493         GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)    374

TABLE 494         GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)           375

TABLE 495         GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)          375

TABLE 496         GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)         376

TABLE 497         GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          376

TABLE 498         GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)    376

12.6.3    REST OF MIDDLE EAST & AFRICA           377

TABLE 499         REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)        377

TABLE 500         REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION) 378

TABLE 501         REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)  378

TABLE 502         REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)  378

TABLE 503         REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)       379

TABLE 504         REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)              379

TABLE 505         REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)              380

TABLE 506         REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)  380

TABLE 507         REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION) 381

TABLE 508         REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)   381

TABLE 509         REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          381

13          COMPETITIVE LANDSCAPE       382

13.1       OVERVIEW        382

13.2       KEY PLAYER STRATEGIES/RIGHT TO WIN          382

TABLE 510         OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET 383

13.3       REVENUE ANALYSIS      384

FIGURE 37         REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET    385

13.4       MARKET SHARE ANALYSIS         385

FIGURE 38         PATIENT ENGAGEMENT SOLUTIONS MARKET: MARKET SHARE ANALYSIS (2022) 386

TABLE 511         PATIENT ENGAGEMENT SOLUTIONS MARKET: DEGREE OF COMPETITION 386

FIGURE 39         PATIENT ENGAGEMENT SOLUTIONS MARKET: RANKING OF KEY COMPANIES (2022) 387

13.5       COMPANY EVALUATION MATRIX          388

13.5.1    STARS  388

13.5.2    EMERGING LEADERS    388

13.5.3    PERVASIVE PLAYERS     388

13.5.4    PARTICIPANTS 388

FIGURE 40         PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPANY EVALUATION MATRIX, 2022      389

13.5.5    COMPANY FOOTPRINT 390

TABLE 512         COMPANY FOOTPRINT (14 COMPANIES)           390

TABLE 513         COMPONENT FOOTPRINT (14 COMPANIES)     391

TABLE 514         APPLICATION FOOTPRINT (14 COMPANIES)     392

TABLE 515         REGIONAL FOOTPRINT (14 COMPANIES)           393

13.6       START-UP/SME EVALUATION MATRIX 394

13.6.1    PROGRESSIVE COMPANIES       394

13.6.2    DYNAMIC COMPANIES 394

13.6.3    RESPONSIVE COMPANIES          394

13.6.4    STARTING BLOCKS       394

FIGURE 41         PATIENT ENGAGEMENT SOLUTIONS MARKET: STARTUP/SME EVALUATION MATRIX (2022)    395

13.6.5    COMPETITIVE BENCHMARKING            396

TABLE 516         PATIENT ENGAGEMENT SOLUTIONS MARKET: DETAILED LIST OF KEY STARTUPS/SMES  396

TABLE 517         PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES)  397

13.7       COMPETITIVE SITUATIONS AND TRENDS         397

13.7.1    PRODUCT LAUNCHES/ENHANCEMENT             397

TABLE 518         PRODUCT LAUNCHES/ENHANCEMENT, 2020–2023         397

13.7.2    DEALS  398

TABLE 519         DEALS, 2020–2023           398

13.7.3    OTHER DEVELOPMENTS           401

TABLE 520         OTHER DEVELOPMENTS, (2020–2023)   401

14          COMPANY PROFILES    402

14.1       KEY PLAYERS   402

*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

14.1.1    MCKESSON CORPORATION       402

TABLE 521         MCKESSON CORPORATION: COMPANY OVERVIEW       402

FIGURE 42         MCKESSON CORPORATION: COMPANY SNAPSHOT (2022)              403

TABLE 522         MCKESSON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED   403

TABLE 523         MCKESSON CORPORATION: PRODUCT LAUNCHES       404

TABLE 524         MCKESSON CORPORATION: DEALS       404

TABLE 525         MCKESSON CORPORATION: OTHER DEVELOPMENTS  405

14.1.2    ORACLE CORPORATION            407

TABLE 526         ORACLE CORPORATION: COMPANY OVERVIEW             407

FIGURE 43         ORACLE CORPORATION: COMPANY SNAPSHOT (2023) 408

TABLE 527         ORACLE CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED          408

TABLE 528         ORACLE CORPORATION: PRODUCT DEVELOPMENTS  409

TABLE 529         ORACLE CORPORATION: DEALS            409

14.1.3    VERADIGM LLC 411

TABLE 530         VERADIGM LLC: COMPANY OVERVIEW 411

FIGURE 44         VERADIGM LLC: COMPANY SNAPSHOT (2021)  412

TABLE 531         VERADIGM LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED              412

TABLE 532         VERADIGM LLC: PRODUCT LAUNCHES 413

TABLE 533         VERADIGM LLC: DEALS 413

TABLE 534         VERADIGM LLC: OTHER DEVELOPMENTS         414

14.1.4    ATHENAHEALTH           415

TABLE 535         ATHENAHEALTH: COMPANY OVERVIEW           415

TABLE 536         ATHENAHEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED          415

TABLE 537         ATHENAHEALTH: PRODUCT ENHANCEMENT  416

TABLE 538         ATHENAHEALTH: DEALS           416

TABLE 539         ATHENAHEALTH: OTHER DEVELOPMENTS      417

14.1.5    ORION HEALTH             419

TABLE 540         ORION HEALTH: COMPANY OVERVIEW 419

TABLE 541         ORION HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED              419

TABLE 542         ORION HEALTH: PRODUCT LAUNCHES 420

TABLE 543         ORION HEALTH: DEALS             420

TABLE 544         ORION HEALTH: OTHER DEVELOPMENTS         421

14.1.6    GETWELLNETWORK, INC.          423

TABLE 545         GETWELLNETWORK, INC.: COMPANY OVERVIEW          423

TABLE 546         GETWELLNETWORK, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED          423

TABLE 547         GETWELLNETWORK, INC.: PRODUCT LAUNCHES          424

TABLE 548         GETWELLNETWORK, INC.: DEALS          425

TABLE 549         GETWELLNETWORK, INC.: OTHER DEVELOPMENTS     426

14.1.7    LINCOR INC.     427

TABLE 550         LINCOR INC.: COMPANY OVERVIEW     427

TABLE 551         LINCOR INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED              427

TABLE 552         LINCOR INC.: OTHER DEVELOPMENTS 428

14.1.8    COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION           429

TABLE 553         COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: COMPANY OVERVIEW  429

FIGURE 45         COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: COMPANY SNAPSHOT (2022)    430

TABLE 554         COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: PRODUCTS/SOLUTIONS/ SERVICES OFFERED  430

TABLE 555         COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: OTHER DEVELOPMENTS           431

14.1.9    GET REAL HEALTH       432

TABLE 556         GET REAL HEALTH: COMPANY OVERVIEW        432

TABLE 557         GET REAL HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED          432

TABLE 558         GET REAL HEALTH: PRODUCT LAUNCHES        433

TABLE 559         GET REAL HEALTH: OTHER DEVELOPMENTS   433

14.1.10  ONEVIEW HEALTHCARE            434

TABLE 560         ONEVIEW HEALTHCARE: COMPANY OVERVIEW             434

FIGURE 46         ONEVIEW HEALTHCARE: COMPANY SNAPSHOT (2022) 434

TABLE 561         ONEVIEW HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED          435

TABLE 562         ONEVIEW HEALTHCARE: PRODUCT LAUNCH/ENHANCEMENT              436

TABLE 563         ONEVIEW HEALTHCARE: DEALS            436

TABLE 564         ONEVIEW HEALTHCARE: OTHER DEVELOPMENTS        437

14.1.11  ADVANCEDMD, INC.     438

TABLE 565         ADVANCEDMD, INC.: COMPANY OVERVIEW      438

TABLE 566         ADVANCEDMD, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED          438

14.1.12  EPIC SYSTEMS CORPORATION 440

TABLE 567         EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW  440

TABLE 568         EPIC SYSTEMS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED   440

TABLE 569         EPIC SYSTEMS CORPORATION: DEALS 441

14.1.13  HARRIS HEALTHCARE  442

TABLE 570         HARRIS HEALTHCARE: COMPANY OVERVIEW   442

TABLE 571         HARRIS HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED          442

TABLE 572         HARRIS HEALTHCARE: DEALS  443

TABLE 573         HARRIS HEALTHCARE: OTHER DEVELOPMENTS            443

14.1.14  MEDICAL INFORMATION TECHNOLOGY, INC.  444

TABLE 574         MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW        444

TABLE 575         MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED   444

TABLE 576         MEDICAL INFORMATION TECHNOLOGY, INC.: DEALS  445

TABLE 577         MEDICAL INFORMATION TECHNOLOGY, INC.: OTHER DEVELOPMENTS           445

(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*

14.2       OTHER PLAYERS           446

14.2.1    KAREO, INC.      446

14.2.2    ECLINICAL WORKS        447

14.2.3    WELLSTACK     448

14.2.4    IQVIA HOLDINGS INC.  448

14.2.5    VIVIFY HEALTH             449

14.2.6    MEDHOST         450

14.2.7    LUMA HEALTH 451

14.2.8    CUREMD HEALTHCARE             451

14.2.9    SONIFI HEALTH             452

14.2.10  ADVANTECH CO., LTD. 452

14.2.11  BARCO 453

15          APPENDIX         454

15.1       DISCUSSION GUIDE      454

15.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             458

15.3       CUSTOMIZATION OPTIONS      460

15.4       RELATED REPORTS       460

15.5       AUTHOR DETAILS         461